pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

Australia's TGA begins five-year transition to new medicine labeling standards

Oct 5, 2026·read at raps ↗RegulatoryNeutral

The Therapeutic Goods Administration has adopted two new labeling standards for medicines in Australia.

The standards will become mandatory after a five-year transition period that starts now.

Pharmaceutical companies will need to revise packaging and patient information to comply within the timeframe.

The change is intended to improve safety and clarity for patients and healthcare providers.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Asia-Pacific Roundup: TGA starts 5-year transition to new Australian medicine labeling standards”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoFDA seeks input on studying psychedelic ibogaineraps
  • 1d agoFDA admonishes Evolus for ‘false and misleading’ social media claimsraps
  • 1d agoRecon: Bayer plans for $2.2B manufacturing site in Ohio; FDA’s CDER launches clinical trial modernization officeraps
  • 4d agoFDA’s device center releases guidance agenda for FY 2027raps
  • 4d agoThis Week at FDA: No Overton vote until after midterms, FDA signals advisory committee support, and moreraps